Abbott Lifts Price of Norvir 400%

Abbott Laboratories has raised the U.S. price of a key AIDS drug by 400%, a move that could roil the market for HIV treatments and has already reignited the debate over drug pricing policies.

The medication is called Norvir, a protease inhibitor that hasn't been a lucrative seller for Abbott but is widely used in small doses to boost the potency of some AIDS combination-drug therapies. Earlier this month, the Abbott Park, Ill., company notified doctors, AIDS groups and pharmacies that it would raise Norvir's wholesale...